NOVARTIS FARMA - PROD.FARM SA

Track this competitor Create a free account to be notified when it wins a contract.

Contracts won: 13
Amount won alone: €7,746,923 excl. VAT
Period: 4 August 2026 – 20 October 2026

Its main clients

Unidade Local de Saúde Santa Maria, E.P.E. · 13 contracts

Where and what

Supplies · 13

Its contracts coming to an end

So many opportunities to take over these contracts when they are re-tendered.

Planned end	Contract	Current holder	Amount
23 November 2026 re-tender around October 2026	2023/0491 - Ruxolitinib [20 mg cáp/comp] Unidade Local de Saúde Santa Maria, E.P.E. framework agreement	NOVARTIS FARMA - PROD.FARM SA 1 bid received	€246,860
27 November 2026 re-tender around October 2026	2023/0491 - Canacinumab [150 mg/ml 1 ml sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. framework agreement	NOVARTIS FARMA - PROD.FARM SA 1 bid received	€154,616
14 December 2026 re-tender around October 2026	2023/0491 - Ruxolitinib [20 mg cáp/comp] Unidade Local de Saúde Santa Maria, E.P.E. framework agreement	NOVARTIS FARMA - PROD.FARM SA 1 bid received	€111,675
23 December 2026 re-tender around October 2026	2026/0006 - Trametinib [2 mg cáp/ comp] Unidade Local de Saúde Santa Maria, E.P.E. framework agreement	NOVARTIS FARMA - PROD.FARM SA 1 bid received	€176,520
23 December 2026 re-tender around October 2026	2023/0491 - Ruxolitinib [15 mg cáp/ comp] Unidade Local de Saúde Santa Maria, E.P.E. framework agreement	NOVARTIS FARMA - PROD.FARM SA 1 bid received	€293,881
23 December 2026 re-tender around October 2026	2023/0491 - Secucinumab [300 mg/2 ml sol inj caneta/ seringa] Unidade Local de Saúde Santa Maria, E.P.E. framework agreement	NOVARTIS FARMA - PROD.FARM SA 1 bid received	€1,639,533
23 December 2026 re-tender around October 2026	2023/0491 - Ribociclib [200 mg cáp/ comp] Unidade Local de Saúde Santa Maria, E.P.E. framework agreement	NOVARTIS FARMA - PROD.FARM SA 1 bid received	€866,190
23 December 2026 re-tender around October 2026	2023/0491 - Ofatumumab [20 mg/0.4 ml sol inj caneta] Unidade Local de Saúde Santa Maria, E.P.E. framework agreement	NOVARTIS FARMA - PROD.FARM SA 1 bid received	€836,535
23 December 2026 re-tender around October 2026	2023/0491 - Ruxolitinib [5 mg cáp/ comp] Unidade Local de Saúde Santa Maria, E.P.E. framework agreement	NOVARTIS FARMA - PROD.FARM SA 1 bid received	€775,848
23 December 2026 re-tender around October 2026	2023/0491 - Canacinumab [150 mg/ml 1 ml sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. framework agreement	NOVARTIS FARMA - PROD.FARM SA 1 bid received	€355,617
23 December 2026 re-tender around October 2026	2023/0491 - Midostaurina [25 mg cáp] Unidade Local de Saúde Santa Maria, E.P.E. framework agreement	NOVARTIS FARMA - PROD.FARM SA 1 bid received	€353,308
27 December 2026 re-tender around October 2026	2026/0006 - Trametinib [2 mg cáp/ comp] Unidade Local de Saúde Santa Maria, E.P.E. framework agreement	NOVARTIS FARMA - PROD.FARM SA 1 bid received	€81,199

Contracts won

Date	Contract	Buyer	Amount
20/10/2026	2026/0006 - Trametinib [2 mg cáp/ comp]	Unidade Local de Saúde Santa Maria, E.P.E.	€81,199
20/10/2026	2026/0006 - Trametinib [2 mg cáp/ comp]	Unidade Local de Saúde Santa Maria, E.P.E.	€176,520
13/10/2026	2023/0491 - Ruxolitinib [15 mg cáp/ comp]	Unidade Local de Saúde Santa Maria, E.P.E.	€293,881
29/09/2026	2023/0491 - Ruxolitinib [20 mg cáp/comp]	Unidade Local de Saúde Santa Maria, E.P.E.	€246,860
29/09/2026	2023/0491 - Ruxolitinib [20 mg cáp/comp]	Unidade Local de Saúde Santa Maria, E.P.E.	€111,675
29/09/2026	2023/0491 - Midostaurina [25 mg cáp]	Unidade Local de Saúde Santa Maria, E.P.E.	€353,308
22/09/2026	2023/0491 - Canacinumab [150 mg/ml 1 ml sol inj frs]	Unidade Local de Saúde Santa Maria, E.P.E.	€154,616
22/09/2026	2023/0491 - Canacinumab [150 mg/ml 1 ml sol inj frs]	Unidade Local de Saúde Santa Maria, E.P.E.	€355,617
08/09/2026	2023/0491 - Ofatumumab [20 mg/0.4 ml sol inj caneta]	Unidade Local de Saúde Santa Maria, E.P.E.	€836,535
08/09/2026	2023/0491 - Ruxolitinib [5 mg cáp/ comp]	Unidade Local de Saúde Santa Maria, E.P.E.	€775,848
11/08/2026	2023/0491 - Ribociclib [200 mg cáp/ comp]	Unidade Local de Saúde Santa Maria, E.P.E.	€866,190
04/08/2026	2026/0002 - Onasemnogene abeparvovec [2 x10e13 vg/ml 22,1 ml sol inj frs]	Unidade Local de Saúde Santa Maria, E.P.E.	€1,855,141
04/08/2026	2023/0491 - Secucinumab [300 mg/2 ml sol inj caneta/ seringa]	Unidade Local de Saúde Santa Maria, E.P.E.	€1,639,533

Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.